InsiderTrades.com logo

VNRX Insider Trading

Insider Ownership Percentage: 10.40%
Insider Buying (Last 12 Months): $599,243.31
Insider Selling (Last 12 Months): $0.00

VolitionRx Insider Trading History Chart

This chart shows the insider buying and selling history at VolitionRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

VolitionRx Share Price & Price History

Current Price: $0.31
Price Change: ▲ Price Increase of +0.027 (9.49%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for VNRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

VolitionRx Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Cameron John ReynoldsCEOBuy20,000$0.35$7,000.002,554,847View SEC Filing Icon  
10/14/2025Cameron John ReynoldsCEOBuy110,000$0.51$56,100.002,534,847View SEC Filing Icon  
10/14/2025Guy Archibald InnesDirectorBuy96,153$0.51$49,038.031,062,967View SEC Filing Icon  
10/14/2025Timothy I StillDirectorBuy48,076$0.51$24,518.761,535,458View SEC Filing Icon  
9/12/2025Cameron John ReynoldsCEOBuy15,000$0.66$9,900.002,624,847View SEC Filing Icon  
8/5/2025Cameron John ReynoldsCEOBuy78,125$0.64$50,000.002,609,847View SEC Filing Icon  
8/5/2025Guy Archibald InnesDirectorBuy78,125$0.64$50,000.00966,814View SEC Filing Icon  
6/12/2025Cameron John ReynoldsCEOBuy12,500$0.59$7,375.002,331,722View SEC Filing Icon  
6/3/2025Guy Archibald InnesDirectorBuy20,000$0.54$10,800.00888,689View SEC Filing Icon  
5/19/2025Cameron John ReynoldsCEOBuy20,000$0.44$8,800.002,319,222View SEC Filing Icon  
5/19/2025Jacob Vincent MicallefInsiderBuy50,000$0.43$21,500.00426,033View SEC Filing Icon  
3/26/2025Cameron John ReynoldsCEOBuy181,818$0.55$99,999.902,299,222View SEC Filing Icon  
12/9/2024Cameron John ReynoldsCEOBuy139,811$0.57$79,692.272,117,404View SEC Filing Icon  
12/9/2024Guy Archibald InnesDirectorBuy174,764$0.57$99,615.48617,085View SEC Filing Icon  
12/9/2024Jacob Vincent MicallefInsiderBuy43,691$0.57$24,903.87394,352View SEC Filing Icon  
8/20/2024Guy Archibald InnesDirectorBuy150,000$0.67$100,500.00406,683View SEC Filing Icon  
1/2/2024Corp Ltd EightMajor ShareholderSell20,000$0.90$18,000.00298,419View SEC Filing Icon  
12/18/2023Salvatore Thomas ButeraCEOBuy10,000$0.83$8,300.0099,350View SEC Filing Icon  
12/15/2023Corp Ltd EightMajor ShareholderSell20,000$0.75$15,000.00318,419View SEC Filing Icon  
12/15/2023Salvatore Thomas ButeraCEOBuy10,000$0.77$7,700.0089,350View SEC Filing Icon  
12/13/2023Rodney Gerard RootsaertInsiderBuy10,000$0.60$6,000.0078,652View SEC Filing Icon  
12/8/2023Cameron John ReynoldsCEOBuy10,000$0.67$6,700.001,704,518View SEC Filing Icon  
11/27/2023Guy Archibald InnesDirectorBuy20,000$0.77$15,400.00627,161View SEC Filing Icon  
11/24/2023Guy Archibald InnesDirectorBuy10,000$0.76$7,600.00607,161View SEC Filing Icon  
11/22/2023Guy Archibald InnesDirectorBuy20,000$0.71$14,200.00597,161View SEC Filing Icon  
11/16/2023Salvatore Thomas ButeraCEOBuy10,000$0.81$8,100.0079,350View SEC Filing Icon  
9/5/2023Phillip BarnesDirectorBuy5,000$1.30$6,500.0024,686View SEC Filing Icon  
8/31/2023Martin Charles FaulkesDirectorBuy9,716$1.28$12,436.481,673,532View SEC Filing Icon  
8/29/2023Jacob Vincent MicallefInsiderBuy11,250$1.24$13,950.0046,250View SEC Filing Icon  
8/25/2023Jacob Vincent MicallefInsiderBuy20,000$1.24$24,800.00235,140View SEC Filing Icon  
8/24/2023Gaetan MichelCOOBuy5,000$1.23$6,150.00212,997View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for VolitionRx (NYSE:VNRX)

8.09% of VolitionRx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VNRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

VolitionRx Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Armistice Capital LLC9,380,425$6.37M0.1%+10.4%8.718%Search for SEC Filing on Google Icon
11/17/2025Lagoda Investment Management L.P.12,487,000$8.48M4.8%+6.7%11.606%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC329,520$0.22M0.0%+70.1%0.306%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC40,733$28K0.0%N/A0.038%Search for SEC Filing on Google Icon
10/7/2025Silverberg Bernstein Capital Management LLC232,082$0.16M0.1%+15.6%0.216%Search for SEC Filing on Google Icon
8/14/2025Armistice Capital LLC8,493,074$6.46M0.1%+3.5%8.168%Search for SEC Filing on Google Icon
8/13/2025Northwestern Mutual Wealth Management Co.68,570$52K0.0%N/A0.066%Search for SEC Filing on Google Icon
7/24/2025Blair William & Co. IL40,000$30K0.0%N/A0.038%Search for SEC Filing on Google Icon
7/9/2025Silverberg Bernstein Capital Management LLC200,782$0.15M0.1%+42.8%0.195%Search for SEC Filing on Google Icon
5/15/2025Armistice Capital LLC8,206,430$4.68M0.1%-3.2%8.143%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC60,638$36K0.0%N/A0.065%Search for SEC Filing on Google Icon
2/17/2025Lagoda Investment Management L.P.7,576,000$4.55M2.5%+24.3%8.176%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp117,875$71K0.0%+32.0%0.127%Search for SEC Filing on Google Icon
2/14/2025Two Sigma Securities LLC48,910$29K0.0%N/A0.053%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC730,448$0.44M0.0%+15.1%0.788%Search for SEC Filing on Google Icon
10/29/2024Ground Swell Capital LLC45,959$28K0.0%+78.8%0.050%Search for SEC Filing on Google Icon
1/17/2024Silverberg Bernstein Capital Management LLC147,038$0.11M0.1%N/A0.187%Search for SEC Filing on Google Icon
11/14/2023Lagoda Investment Management L.P.3,882,850$2.68M1.8%-1.2%4.969%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
VolitionRx logo
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
Read More on VolitionRx

Today's Range

Now: $0.31
Low: $0.28
High: $0.32

50 Day Range

MA: $0.43
Low: $0.28
High: $0.68

52 Week Range

Now: $0.31
Low: $0.27
High: $0.94

Volume

2,388,538 shs

Average Volume

491,185 shs

Market Capitalization

$38.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of VolitionRx?

VolitionRx's top insider investors include:
  1. Cameron John Reynolds (CEO)
  2. Timothy I Still (Director)
  3. Guy Archibald Innes (Director)
  4. Jacob Vincent Micallef (Insider)
  5. Corp Ltd Eight (Major Shareholder)
  6. Salvatore Thomas Butera (CEO)
  7. Rodney Gerard Rootsaert (Insider)
Learn More about top insider investors at VolitionRx.

Who are the major institutional investors of VolitionRx?

VolitionRx's top institutional investors include:
  1. Lagoda Investment Management L.P. — 11.61%
  2. Armistice Capital LLC — 8.72%
  3. Citadel Advisors LLC — 0.31%
  4. Silverberg Bernstein Capital Management LLC — 0.22%
  5. Virtu Financial LLC — 0.04%
Learn More about top institutional investors of VolitionRx stock.

Which institutional investors are buying VolitionRx stock?

During the last quarter, VNRX stock was acquired by institutional investors including:
  1. Armistice Capital LLC
  2. Lagoda Investment Management L.P.
  3. Citadel Advisors LLC
  4. Virtu Financial LLC
  5. Silverberg Bernstein Capital Management LLC
Within the previous year, these company insiders have bought VolitionRx stock:
  1. Cameron John Reynolds (CEO)
  2. Timothy I Still (Director)
  3. Guy Archibald Innes (Director)
  4. Jacob Vincent Micallef (Insider)
  5. Corp Ltd Eight (Major Shareholder)
  6. Salvatore Thomas Butera (CEO)
Learn More investors buying VolitionRx stock.